79 related articles for article (PubMed ID: 11851323)
1. Towards Alzheimer's beta-amyloid vaccination.
Frenkel D; Solomon B
Biologicals; 2001; 29(3-4):243-7. PubMed ID: 11851323
[TBL] [Abstract][Full Text] [Related]
2. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.
Solomon B
Vaccine; 2007 Apr; 25(16):3053-6. PubMed ID: 17287054
[TBL] [Abstract][Full Text] [Related]
3. Generation of anti-beta-amyloid antibodies via phage display technology.
Frenkel D; Dori M; Solomon B
Vaccine; 2004 Jun; 22(19):2505-8. PubMed ID: 15193416
[TBL] [Abstract][Full Text] [Related]
4. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
Solomon B
Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
[TBL] [Abstract][Full Text] [Related]
5. Generation of auto-antibodies towards Alzheimer's disease vaccination.
Frenkel D; Kariv N; Solomon B
Vaccine; 2001 Mar; 19(17-19):2615-9. PubMed ID: 11257400
[TBL] [Abstract][Full Text] [Related]
6. Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration.
Frenkel D; Katz O; Solomon B
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11455-9. PubMed ID: 11027345
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes.
Esposito M; Luccarini I; Cicatiello V; De Falco D; Fiorentini A; Barba P; Casamenti F; Prisco A
Mol Immunol; 2008 Feb; 45(4):1056-62. PubMed ID: 17850871
[TBL] [Abstract][Full Text] [Related]
8. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
9. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
[TBL] [Abstract][Full Text] [Related]
10. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
Geylis V; Steinitz M
Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
[TBL] [Abstract][Full Text] [Related]
12. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
13. Polypeptide conjugates comprising a beta-amyloid plaque-specific epitope as new vaccine structures against Alzheimer's disease.
Manea M; Mezö G; Hudecz F; Przybylski M
Biopolymers; 2004; 76(6):503-11. PubMed ID: 15499564
[TBL] [Abstract][Full Text] [Related]
14. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R
Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612
[TBL] [Abstract][Full Text] [Related]
15. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.
Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P
Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106
[TBL] [Abstract][Full Text] [Related]
16. Zinc binding agonist effect on the recognition of the beta-amyloid (4-10) epitope by anti-beta-amyloid antibodies.
Zirah S; Stefanescu R; Manea M; Tian X; Cecal R; Kozin SA; Debey P; Rebuffat S; Przybylski M
Biochem Biophys Res Commun; 2004 Aug; 321(2):324-8. PubMed ID: 15358179
[TBL] [Abstract][Full Text] [Related]
17. Design, structural, and immuno-analytical properties of antigenic bioconjugates comprising a beta-amyloid-plaque specific epitope.
Manea M; Przybylski M; Hudecz F; Mezö G
Biopolymers; 2008; 90(2):94-104. PubMed ID: 18183582
[TBL] [Abstract][Full Text] [Related]
18. Design and development of non-fibrillar amyloid beta as a potential Alzheimer vaccine.
Subramanian S; Bandopadhyay D; Mishra PK; Mathew M; John M
Biochem Biophys Res Commun; 2010 Apr; 394(2):393-7. PubMed ID: 20214884
[TBL] [Abstract][Full Text] [Related]
19. Human monoclonal antibodies against amyloid-beta from healthy adults.
Geylis V; Kourilov V; Meiner Z; Nennesmo I; Bogdanovic N; Steinitz M
Neurobiol Aging; 2005 May; 26(5):597-606. PubMed ID: 15708434
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutic strategies for prevention and treatment of Alzheimer's disease.
Solomon B
DNA Cell Biol; 2001 Nov; 20(11):697-703. PubMed ID: 11788047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
